Hans Thorleif Moller

Fondatore presso Ranger Biotechnologies A/S

Non-Energy Minerals

Commercial Services

Health Technology

Profilo

Hans Thorleif Moller is the founder.
He founded Profylakse ApS in 1999.
He also founded Ranger Biotechnologies A in 2009, where he currently holds the title of Chief Executive Officer & Director.
In addition to his founding positions, Dr. Moller has worked as a Principal at CEM Innovation A.

Posizioni attive di Hans Thorleif Moller

Società	Posizione	Inizio
Ranger Biotechnologies A/S Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark.	Fondatore	01/07/2009

Tutte le posizioni attive di Hans Thorleif Moller

Precedenti posizioni note di Hans Thorleif Moller

Società	Posizione	Fine
CEM Innovation A/S CEM Innovation A/S Construction MaterialsNon-Energy Minerals CEM Innovation A/S develops and supplies cement products. The firm's products are used in the engineering, construction, and other industries. The company is headquartered in Sonderso, Denmark.	Corporate Officer/Principal	18/03/2011
Profylakse ApS Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations.	Fondatore	-

Vedi nel dettaglio l'esperienza di Hans Thorleif Moller

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Hans Thorleif Moller

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
CEM Innovation A/S CEM Innovation A/S Construction MaterialsNon-Energy Minerals CEM Innovation A/S develops and supplies cement products. The firm's products are used in the engineering, construction, and other industries. The company is headquartered in Sonderso, Denmark.	Non-Energy Minerals
Ranger Biotechnologies A/S Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark.	Commercial Services
Profylakse ApS Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations.	Health Technology

Vedi le connessioni aziendali